Logopenic progressive aphasia

From WikiMD's WELLNESSPEDIA

Logopenic progressive aphasia (LPA) is a type of aphasia characterized by difficulties in language expression and comprehension, despite preserved articulation and grammar. It is one of the three variants of primary progressive aphasia (PPA), the other two being semantic dementia and progressive nonfluent aphasia.

Symptoms[edit]

The main symptom of LPA is difficulty in retrieving words and names. This is often accompanied by pauses in speech. Patients may also have difficulty understanding complex sentences. However, unlike other forms of PPA, patients with LPA maintain the ability to produce grammatically correct sentences and their articulation remains intact.

Causes[edit]

LPA is caused by the degeneration of the left posterior perisylvian region of the brain, which includes the inferior parietal lobule and the posterior part of the superior temporal gyrus. This degeneration is often associated with Alzheimer's disease.

Diagnosis[edit]

Diagnosis of LPA is based on the presence of the characteristic symptoms and the exclusion of other causes of aphasia. Neuroimaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET) can be used to identify the characteristic brain abnormalities associated with LPA.

Treatment[edit]

There is currently no cure for LPA. Treatment is focused on managing symptoms and improving quality of life. This may involve speech and language therapy, and in some cases, medication to slow the progression of the disease.

Prognosis[edit]

The prognosis for LPA is poor, with most patients experiencing a progressive decline in language abilities over time. However, the rate of progression can vary widely between individuals.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.